Literature DB >> 22948140

Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid β and other toxins by decreasing mitochondrial respiration and reactive oxygen species production.

Jordan T Newington1, Tim Rappon, Shawn Albers, Daisy Y Wong, R Jane Rylett, Robert C Cumming.   

Abstract

We previously demonstrated that nerve cell lines selected for resistance to amyloid β (Aβ) peptide exhibit elevated aerobic glycolysis in part due to increased expression of pyruvate dehydrogenase kinase 1 (PDK1) and lactate dehydrogenase A (LDHA). Here, we show that overexpression of either PDK1 or LDHA in a rat CNS cell line (B12) confers resistance to Aβ and other neurotoxins. Treatment of Aβ-sensitive cells with various toxins resulted in mitochondrial hyperpolarization, immediately followed by rapid depolarization and cell death, events accompanied by increased production of cellular reactive oxygen species (ROS). In contrast, cells expressing either PDK1 or LDHA maintained a lower mitochondrial membrane potential and decreased ROS production with or without exposure to toxins. Additionally, PDK1- and LDHA-overexpressing cells exhibited decreased oxygen consumption but maintained levels of ATP under both normal culture conditions and following Aβ treatment. Interestingly, immunoblot analysis of wild type mouse primary cortical neurons treated with Aβ or cortical tissue extracts from 12-month-old APPswe/PS1dE9 transgenic mice showed decreased expression of LDHA and PDK1 when compared with controls. Additionally, post-mortem brain extracts from patients with Alzheimer disease exhibited a decrease in PDK1 expression compared with nondemented patients. Collectively, these findings indicate that key Warburg effect enzymes play a central role in mediating neuronal resistance to Αβ or other neurotoxins by decreasing mitochondrial activity and subsequent ROS production. Maintenance of PDK1 or LDHA expression in certain regions of the brain may explain why some individuals tolerate high levels of Aβ deposition without developing Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948140      PMCID: PMC3481323          DOI: 10.1074/jbc.M112.366195

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Functional mitochondria are required for amyloid beta-mediated neurotoxicity.

Authors:  S M Cardoso; S Santos; R H Swerdlow; C R Oliveira
Journal:  FASEB J       Date:  2001-06       Impact factor: 5.191

2.  Specificity of resistance to oxidative stress.

Authors:  Richard Dargusch; David Schubert
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

3.  Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins.

Authors:  Kelly T Dineley; Xuefeng Xia; Duy Bui; J David Sweatt; Hui Zheng
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

Review 4.  Hexokinase binding to mitochondria: a basis for proliferative energy metabolism.

Authors:  S G Golshani-Hebroni; S P Bessman
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

5.  Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis.

Authors:  Huasheng Lu; Robert A Forbes; Ajay Verma
Journal:  J Biol Chem       Date:  2002-04-09       Impact factor: 5.157

6.  Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria.

Authors:  Sandra Morais Cardoso; Russell H Swerdlow; Catarina R Oliveira
Journal:  Brain Res       Date:  2002-03-29       Impact factor: 3.252

7.  Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells.

Authors:  Robert C Cumming; Richard Dargusch; Wolfgang H Fischer; David Schubert
Journal:  J Biol Chem       Date:  2007-08-29       Impact factor: 5.157

8.  The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide.

Authors:  Thomas Soucek; Robert Cumming; Richard Dargusch; Pamela Maher; David Schubert
Journal:  Neuron       Date:  2003-07-03       Impact factor: 17.173

Review 9.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

10.  Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells.

Authors:  Thomas McFate; Ahmed Mohyeldin; Huasheng Lu; Jay Thakar; Jeremy Henriques; Nader D Halim; Hong Wu; Michael J Schell; Tsz Mon Tsang; Orla Teahan; Shaoyu Zhou; Joseph A Califano; Nam Ho Jeoung; Robert A Harris; Ajay Verma
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

View more
  40 in total

1.  Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.

Authors:  Benjamin Kolisnyk; Mohammed A Al-Onaizi; Pedro H F Hirata; Monica S Guzman; Simona Nikolova; Shahar Barbash; Hermona Soreq; Robert Bartha; Marco A M Prado; Vania F Prado
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  ATM deficiency promotes progression of CRPC by enhancing Warburg effect.

Authors:  Lingfan Xu; Enze Ma; Tao Zeng; Ruya Zhao; Yulei Tao; Xufeng Chen; Jeff Groth; Chaozhao Liang; Hailiang Hu; Jiaoti Huang
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

3.  Reply to Biskup et al. and Tu et al.: Sex differences in metabolic brain aging.

Authors:  Manu S Goyal; Andrei G Vlassenko; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

4.  Synaptic Activity Drives a Genomic Program That Promotes a Neuronal Warburg Effect.

Authors:  Carlos Bas-Orth; Yan-Wei Tan; David Lau; Hilmar Bading
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

Review 5.  Resting state functional connectivity in preclinical Alzheimer's disease.

Authors:  Yvette I Sheline; Marcus E Raichle
Journal:  Biol Psychiatry       Date:  2013-01-04       Impact factor: 13.382

Review 6.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

Review 7.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

8.  Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism.

Authors:  Zheng Tan; Na Xie; Huachun Cui; Douglas R Moellering; Edward Abraham; Victor J Thannickal; Gang Liu
Journal:  J Immunol       Date:  2015-05-11       Impact factor: 5.422

9.  Brain aerobic glycolysis functions and Alzheimer's disease.

Authors:  Andrei G Vlassenko; Marcus E Raichle
Journal:  Clin Transl Imaging       Date:  2014-12-10

10.  Protective effects of cardiac resynchronization therapy in a canine model with experimental heart failure by improving mitochondrial function: a mitochondrial proteomics study.

Authors:  Xue Gong; Ziqing Yu; Zheyong Huang; Liqi Xie; Nianwei Zhou; Jingfeng Wang; Yixiu Liang; Shengmei Qin; Zhenning Nie; Liming Wei; Zheng Li; Shijun Wang; Yangang Su; Junbo Ge
Journal:  J Interv Card Electrophysiol       Date:  2020-06-02       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.